Recent Research | Page 4 | Aplastic Anemia and MDS International Foundation

Recent Research

Compiled for your convenience are the latest articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology. Articles are obtained from the National Library of Medicine’s MEDLINE database and date back to 2010.

Article Title Original Publication Datesort descending Journal Bone Marrow Disease
Are T-cell dysfunctions the other side of the moon in the pathogenesis of myelodysplastic syndromes? Feb 2012 Eur J Haematol myelodysplastic syndromes (MDS)
5-Azacitidine efficacy and safety in patients aged >65 years with myelodysplastic syndromes outside clinical trials Feb 2012 Leuk Lymphoma myelodysplastic syndromes (MDS)
HLA-Matched Sibling Transplantation for Severe Aplastic Anemia: Impact of HLA DR15 Antigen Status on Engraftment, Graft-versus-Host Disease, and Overall Survival. Feb 2012 Biol Blood Marrow Transplant aplastic anemia
Seroreactivity to LGL leukemia-specific epitopes in aplastic anemia, myelodysplastic syndrome and paroxysmal nocturnal hemoglobinuria: results of a bone marrow failure consortium study. Mar 2012 Leuk Res paroxysmal nocturnal hemoglobinuria (PNH)
Rabbit-antithymocyte globulin combined with cyclosporin A as a first-line therapy: improved, effective, and safe for children with acquired severe aplastic anemia. Mar 2012 J Cancer Res Clin Oncol aplastic anemia
New comprehensive cytogenetic scoring system for primary myelodysplastic syndromes (MDS) and oligoblastic acute myeloid leukemia after MDS derived from an international database merge Mar 2012 J Clin Oncol myelodysplastic syndromes (MDS)
Prognostic relevance of cytogenetic systems in myelodysplastic syndromes. Mar 2012 Leuk Lymphoma myelodysplastic syndromes (MDS)
Paroxysmal nocturnal hemoglobinuria and concurrent JAK2(V617F) mutation Mar 2012 Blood Cancer J paroxysmal nocturnal hemoglobinuria (PNH)
Asymptomatic cerebral bleeds in patients with aplastic anemia. Mar 2012 Ann Hematol aplastic anemia
Alternative donor HSCT in refractory acquired aplastic anemia - Prevention of graft rejection and graft versus host disease by immunoablative conditioning and graft manipulation Mar 2012 Pediatr Transplant aplastic anemia